精神科医のための認知症予防

出版社： ワールドプランニング
著者：
発行日： 2023-03-01
分野： 臨床医学：内科  >  精神医学
ISBN： 9784863512399
電子書籍版： 2023-03-01 （第1版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,180 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,926 円(税込)

購入する

商品紹介

認知機能障害、精神・神経的徴候など、認知症の前駆となる病態をまとめ、認知症とかかわりの深い精神疾患・生活習慣病と医学的予防について解説。多職種スタッフに役立つ認知症予防のノウハウも紹介する。

目次

  • 第1章　認知症予防と初期対応
    　1．総論
    　2．高齢者の心性と接し方
    　3．最新の認知症予防
    　4．認知機能障害
    　5．精神・神経的徴候
    　6．身体的特徴
    　7．認知症の前駆状態、初期状態にみられる非認知機能障害

    第2章　認知症とかかわりの深い精神疾患、生活習慣病
    　1．総説
    　2．精神科疾患：危険因子や誘発因子としての関連
    　3．身体的疾患
    　4．介護者の問題

    第3章　認知症予防のノウハウ
    　1．認知症当事者の心理
    　2．デイケアを実施するうえでのポイント
    　3．デイケア実施の具体的ノウハウ
    　4．認知症の人の主体性を尊重したデイサービスでの支援
    　5．予防活動におけるインストラクターが知るべきこと
    　6．認知症予防とかかりつけ医・認知症サポート医
    　7．地域に活かす認知症疾患医療センターの役割
    　8．地域に活かす認知症疾患医療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 : 認知症予防と初期対応

P.26 掲載の参考文献
1) 厚生労働省:認知症施策推進大綱. www.mhlw.go.jp/content/000522832.pdf
 
2) 朝田隆:厚生労働科学研究費補助金(認知症対策総合研究事業)総合研究報告書「都市部における認知症有病率と認知症の生活機能障害への対応」. 平成23年度～平成24年度総合研究報告書, 2013.
 
3) 老年医学会, 広島大学:コロナ拡大による生活変化-認知症患者の症状に影響. www./akuji.co.jp/entry80798.html
 
P.46 掲載の参考文献
1) Plassman BL, Williams JW Jr, Burke JR, et al.:Systematic review:Factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 153;182-193(2010).
 
2) Jin-Tai Y, Wei X, Chen-Chen T, et al.:Evidence-based prevention of Alzheimer's disease:systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. JNNP. 91;1140-1141(2020).
 
3) Livingstone PG, Huntley J, Sommerlad A, Ames D, et al.:Dementia prevention, intervention, and care:2020 report of the Lancet commission. The Lancet commissions. 398;413-446(2020).
 
4) Livingston G, Sommerlad A, Orgeta V, et al.:Dementia prevention, intervention, and care. Lancet. 390;2673-2734(2017).
 
5) Maharani A, Dawes P, Nazroo J, et al. :Longitudinal relationship between hearing aiduse and cognitive function in older Americans. J Am Geriatr Soc. 66;1130-1136(2018).
 
6) Sommerlad A, Ruegger J, Sigh-Manoux A, et al. :Marriage and risk of dementia:systemic review and meta-analysis of observational studies. JNNP. 89;231-238(2018).
 
7) Saito T, Murata C, Saito M, et al.:Influence of social relationship domains and their combinations on incident dementia:a prospective cohort study. J Epidemiol Community Health. 72;7-12(2018).
 
8) Portugal EMM, Cevada T, Monteiro-Junior RS, et al. :Neuroscience of exercise:From neurobiology mechanisms to mental health. Neuropsychobioloy. 68;1-14(2013).
 
P.53 掲載の参考文献
1) Kryscio RJ, et al.:Self-reported memory complaints;implications from a longitudinal cohort with autopsies. Neurology, 83:1359-1365(2014).
 
2) Koppara A, et al.:Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimer's & Dementia:Diagnosis, Assessment & Disease Monitoring, 1:194-205(2015).
 
3) Ptacek SG, et al.:Subjective Cognitive Impairment Subjects in Our Clinical Practice. Dement Geriatr Cogn Disord Extra, 4:419-430(2014).
 
4) Jessen F, Amariglio RE, van Boxtel M, Breteler M, et al.:Subjective Cognitive Decline Initiative (SCD-I) Working Group;A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement, 10(6):844-852(2014).
 
5) Kiuchi K, et al. :Gray and White Matter Changes in Subjective Cognitive Impairment, Amnestic Mild Cognitive Impairment and Alzheimer's Disease;A Voxel-Based Analysis Study. PLOS ONE 9(8):e104007(2014).
PubMed
6) Lukas S, et al.:Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment, Neurology, 79:1332-1339(2012).
 
7) Nadine S.:Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment. Dement Geriatr Cogn Disord, 29:75-81(2010).
 
8) Hooghiemstra AM. et al.:Gait Speed and Grip Strength Reflect Cognitive Impairment and Are Modestly Related to Incident Cognitive Decline in Memory Clinic Patients with Subjective Cognitive Decline and Mild Cognitive Impairment:Findings From the 4C Study. J Gerontol A Biol Sci Med Sci, 72(6):846-85.
PubMed
9) Lopez-Sanz D, et al.:Functional Connectivity Disruption in Subjective Cognitive Decline and Mild Cognitive Impairment:A Common Pattern of Alterations. Front. Aging Neurosci. 9:109(2017).
PubMed
10) C-P Chung, et al. :Cerebral Artery Pulsatility is Associated with Cognitive Impairment and Predicts Dementia in Individuals with Subjective Memory Decline or Mild Cognitive Impairment. Journal of Alzheimer's Disease, 60:625-632(2017).
 
11) Shirooka H et al.:Subjective cognitive decline and fall risk in community-dwelling older adults with or without objective cognitive decline. Aging Clin Exp Res, 30(5):457-462(2017 Jul 19). doi:10.1007/s40520-017-0799-3. [Epub ahead of print.
PubMed
12) Teipel SJ et al.:Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol Aging, 57:143-152.
PubMed
13) Mortby ME et al:Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr, 30(2):221-232(2017 Sep 21). doi:10.1017/S1041610217001909. [Epub ahead of print]
 
14) Y. Balash et al.:Subjective memory complaints in elders:depression, anxiety, or cognitive decline? Acta Neurol Scand, 127:344-350(2013).
 
15) Molinuevo JL, et al.:Implementation of subjective cognitive decline criteria in research studies, Alzheimers Dement, 13(3):296-311(2017).
 
16) Hao L. et al. :Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population. J Alzheimers Dis, 60(2):371-388(2017).
 
17) Kristine Y et al.:Olfaction and risk of dementia in a biracial cohort of older adults, Neurology, 88:456-462(2017).
 
18) Hironori O et al. :Differences physical, cognitive, and mental function between presence or absence of dementia symptoms in elderly woman. JAHS, 7(2):46-53(2016).
 
19) Ramakers IH, Visser PJ, Bittermann AJ, Ponds RW, et al. :Characteristics of help-seeking behavior in subjects with subjective memory complaints at a memory clinic;A case-control study. Int J Geriatr Psychiatry, 24(2):190-196(2009).
 
20) Rami L, Mollica MA, Garcia-Sanchez C, Saldana J, et al.:The Subjective Cognitive Decline Questionnaire (SCD-Q) ;A validation study. J Alzheimers Dis, 41(2):453-466(2014).
 
P.61 掲載の参考文献
1) Folstein MF, Folstein SE, McHugh PR, Se F:"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12:189-198(1975).
 
2) Ballard C, Day S, Sharp S, Wing G, Sorensen S:Neuropsychiatric symptoms in dementia:importance and treatment considerations. Int Rev Psychiatry, 20:396-404(2008).
 
3) Mortby ME, Burns R, Eramu dugolla R, Ismail Z, et al.:Neuropsychiatric symptoms and cognitive impairment:Understanding the importance of co-morbid symptoms. J Alzheimers Dis, 59:141-153(2017).
 
4) Ismail Z, Elbayoumi H, Smith EE, Fischer CE, et al.:A Systematic Review and Meta-Analysis for the Prevalence of Depression in Mild Cognitive Impairment. JAMA Psychiatry, 74:58-67(2017).
 
5) Rosenberg PB, Mielke MM, Appleby BS, Oh ES, et al.:The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry, 21:685-695(2013).
 
6) Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, et al.:Mild behavioral impairment and risk of dementia:A prospective cohort study of 358 patients. J Clin Psychiatry, 70:584-592(2009).
 
7) Ismail Z, Smith EE, Geda Y, Sultzer D, et al.:Neuropsychiatric symptoms as early manifestations of emergent dementia:Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement, 12:195-202(2016).
 
8) Zahinoor Ismail, Luis Aguera-Ortiz, MD, Henry Brodaty, Alicja Cieslak, et al.:The Mild Behavioral Impairment Checklist (MBI-C):A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis, 56:929-938(2017).
 
9) Matsuoka T, Ismail Z, Narumoto J:Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic. J Alzheimer Dise, 70:503-513(2019).
 
10) Asada T, Kakuma T, Ota M, Lebowitz AJ, et al.:Development of informant-reported or self-reported MCI-J questionnaire. Int. J. Geratry Psychiatry, 37(8)(2022).
 
P.71 掲載の参考文献
1) Bredesen DE:The end of Alzheimer's Vermilion (August 22, 2017);Language:English;ISBN-10:1785041223
 
2) Livingston, G, Sommerlad, A, Orgeta, V, et al.:Dementia prevention, intervention, and care. Lancet. 390:2673-2734(2017).
 
3) Petersen RC, Smith GE, Waring SC, et al.:Mild Cognitive Impairment;Clinical characterization and outcome. Arch Neurol, 56:303-308(1999).
 
4) Petersen RC, Morris JC:Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol, 62:1160-1163(2005).
 
5) Ritchie K, Artero S, Touchon J:Classification criteria for mild cognitive impairment:a population-based validation study. Neurology, 56:37-42(2001).
 
6) Petersen RC, Morris JC:Clinical features. In Mild Cognitive Impairment. (Petersen RC, ed.) pp15-39, Oxford UP. New York(2003).
 
7) Bruscoli M, Lovestone S:Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr, 16:129-140(2004).
 
8) Ward A, Tardiff S, Dye C, et al.:Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia:A Systematic Review of the Literature. Dement Geriatr Cogn Dis Extra. 3:320-332(2013).
 
9) Canevelli M, Grande G, Lacorte E, et al.:Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition:A Systematic Review of Literature and Meta-Analysis. J Am Med Dir Assoc. 17:943-948(2016).
 
10) Sachdev PS, Lipnicki DM, Crawford J, et al.:Factors Predicting Reversion from Mild Cognitive Impairment to Normal Cognitive Functioning:A Population-Based Study. PLoS ONE. 8:e59649(2013).
PubMed
11) Johnson KA, Sperling RA, Gidicsin CM, et al.:Florbetapir(F18-AV-45)PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimer's & dementia :the journal of the Alzheimer's Association. 9(5 Suppl):S72-83(2013).
 
12) Diniz BSO, Pinto JRJA, Forlenza OV:Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. The World journal of Biological Psychiatry, 9:172-182(2008).
 
13) Giau VV, Bagyinszky E, Soo S:Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment. Int J Mol Sci. 20:4149(2019).
 
14) Uchida K, Shan L, Suzuki H, et al.:Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline. Alzheimers Dement(Amst). 15:270-280(2015).
 
15) Petersen RC, Lopez O, Armstrong MJ, et al.:Practice guideline update summary:Mild cognitive impairment-Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology". Neurology. Special article, 90:1-10 (2018).
 
16) Panza F, Solfrizzi V, Frisardi V, et al.:Different models of frailty in predementia and dementia syndromes. J Nutr Health Aging, 15:711-719(2011).
 
P.80 掲載の参考文献
1) 馬場元:脳神経内科診療に役立つ精神科の知識うつ病・抑うつ状態とアパシー. BRAIN and NERVE, 70:961-970(2018).
 
2) 馬場元:うつ状態・アパシー. 認知症ハンドブック第2版(中島健二ほか編), 医学書院, 東京, 92-99(2020).
 
3) DSM-5 精神疾患の診断・統計マニュアル. 医学書院, 東京 (2014).
 
4) 杉下守弘, 朝田隆:高齢者用うつ尺度短縮版-日本版(Geriatric Depression Scale-Short Version-Japanese, GDS-S-J)の作成について. 認知神経科学, 11:87-90(2009).
 
5) 日本うつ病学会「気分障害の治療ガイドライン検討委員会」:日本うつ病学会治療ガイドライン 高齢者のうつ病治療ガイドライン. https://www.secretariat.ne.jp/jsmd/iinkai/katsudou/data/guideline_20200713.pdf
 
P.90 掲載の参考文献
1) International classification of sleep disorders, 3rd edition (ICSD-3). American Academy of Sleep Medicine, Darien, IL(2014).
 
2) Rongve A, Boeve BF, Aarsland D. Frequency and correlates of caregiverreported sleep disturbances in a sample of persons with early dementia. J Am Geriatr Soc. 58:480-486(2010).
 
3) 田ヶ谷浩邦, 清水徹男:一般医療機関における睡眠障害スクリーニングガイドライン. in睡眠医療, ライフ・サイエンス社, 267-270(2008).
 
4) Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L:The risk of neurodegeneration in REM sleep behavior disorder:A systematic review and meta-analysis of longitudinal studies. Sleep Med Rev.,43:37-46 (2019).
PubMed
5) 三島和夫:睡眠薬の適正使用・休薬ガイドライン. 睡眠薬の適正使用及び減量・中止のための診療ガイドラインに関する研究班(編). じほう, 東京 (2014).
 
P.100 掲載の参考文献
1) Meagher D, Moran M, Raju B, Leonard M, Donnelly S, Saunders J, Trzepacz P.:A new data-based motor subtype schema for delirium. J Neuropsychiatry Clin Neurosci, 20:185-193(2008).
 
2) Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI:Clarifying confusion;the confusion assessment method. A new method for detection of delirium. Ann Intern Med, 113:941-948(1990).
 
3) Kato M, Kishi Y, Okuyama T, Trzepacz PT, Hosaka T:Japanese version of the Delirium Rating Scale, Revised-98(DRS-R98-J);reliability and validity. Psychosomatics, 51:425-431(2010).
 
P.113 掲載の参考文献
1) 日本老年医学会:高齢者の定義と区分に関する提言. https://jpn-geriatsoc.or.jp/proposal/pdf/definition_01.pdf
 
2) Yoshimura N, et al.:Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women:the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab, 27:620-628(2009).
 
3) Walston J, et al.:Research agenda for frailty in older adults;toward a better understanding of physiology and etiology:summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc, 54:991-1001(2006).
 
4) Lana A, et al.:Dairy consumption and risk of frailty in older adults:a prospective cohort study. J Am Geriatr Soc, 63:1852-1860(2015).
 
5) Kim H, et al.:Effects of exercise and amino acid supplementation on body composition and physical function in community dwelling elderly Japanese sarcopenic women:a randomized controlled trial. J Am Geriatr Soc, 60:16-23(2012).
 
P.121 掲載の参考文献
1) Wilson RS, Schneider JA, Arnold SE, et al.:Olfactory identification and incidence of mild cognitive impairment in old age. Arch Gen Psychiatry, 64:802-808(2007).
 
2) Devanand DP, Liu X, Tabert MH, et al.:Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry, 64:871-879(2008).
 
3) Iritani O, Okuno T, Miwa T, et al. :Olfactory-cognitive index distinguishes involvement of frontal lobe shrinkage, as in sarcopenia from shrinkage of medial temporal areas, and global brain, as in Kihon Checklist frailty/dependence, in older adults with progression of normal cognition to Alzheimer's disease. Geriatr Gerontol Int, 21:291-298(2021).
 
4) Schubert CR, Cruickshanks KJ, Nondahl DM, et al.:Association of exercise with lower long-term risk of olfactory impairment in older adults. JAMA Otolaryngol Head Neck Surg, 139:1061-1066(2013).
 
5) Hummel T, Rissom K, Reden J, et al.:Effects of olfactory training in patients with olfactory loss. Laryngoscope, 119:496-499(2009).
 
6) Livingston G, Huntley J, Sommerlad A, et al.:Dementia prevention, intervention, and care:2020 report of the Lancet Commission. Lancet, 396:413-446(2020).
 
7) Amieva H, Ouvrard C, Giulioli C, et al.:Self-Reported Hearing Loss, Hearing Aids, and Cognitive Decline in Elderly Adults:A 25-Year Study. J Am Geriatr Soc, 63:2099-2104(2015).
 
8) Lawrence BJ, Jayakody DMP, Henshaw H, et al.:Auditory and Cognitive Training for Cognition in Adults With Hearing Loss:A Systematic Review and Meta-Analysis. Trends Hear, 22:2331216518792096(2018).
PubMed
9) Claes AJ, Van de Heyning P, Gilles A, et al.:Cognitive outcomes after cochlear implantation in older adults:A systematic review. Cochlear Implants Int, 19:239-254(2018).
 
P.132 掲載の参考文献
1) Sakakibara R, Tateno F, Aiba Y, Ogata T, Terada H, Inaoka T, Nakatsuka T, Katsuragawa S:Prevalence of triple/dual disease(Alzheimer's disease, Lewy body disease, and white matter disease). 27 February 2020. https://doi.org/10.1111/ncn3.12377
 
2) Sakakibara R, Uchiyama T, Yamanishi T, et al.:Dementia and lower urinary dysfunction:with a reference to anticholinergic use in elderly population. Int J Urol, 15:778-788(2008).
 
3) 榊原隆次:認知症患者さんの排泄障害(解説) 日本創傷・オストミー・失禁管理学会誌, 20(1):8-15(2016).
 
4) 榊原隆次・関戸哲利・西村かおる (編):認知症の排泄ケア:ベッドサイドマニュアル. 中外医学社, (2020:in press).
 
5) 西村かおる:特集「歩行障害・認知症をともなうLUTSの診方」[歩行障害・認知症をともなうLUTSの治療とケア]歩行障害・認知症をともなうLUTSの在宅ケア. 排尿障害プラクティス, 26:62-69(2018).
 
6) 榊原隆次, 土井啓員, 岸雅彦, 舘野冬樹, 露崎洋平:消化管自律神経機能検査レビュー. 自律神経機能検査(第5版), 日本自律神経学会編, 文光堂, 東京, 342-344(2015).
 
7) 榊原隆次, 福土審(編):神経・精神疾患による消化管障害:ベッドサイドマニュアル. 中外医学社, 東京 (2019).
 
P.139 掲載の参考文献
1) Fujishiro H, Iseki E, Nakamura S, et al.:Dementia with Lewy bodies:early diagnostic challenges. Psychogeriatrics. 13:128-138(2013).
 
2) Takahashi S, Mizukami K, Arai T, et al.:Ventilatory response to hypercapnia predeicts dementia with Lewy bodies in late-onset major depressive disorder. J Alzheimers Dis., 50(3):751-758(2016).
 
3) Nagao S, Yokota O, Ikeda C, et al.:Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci. 264(4):317-31(2014).
 
4) Kobayashi K, Nakano H, Akiyama N, et al.:Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. Int J Geriatr Psychiatry, 30;663-668(2015).
 
5) Chiba Y, Fujishiro H, Iseki E, et al.:Retrospective survey of prodromal symptoms in dementia with Lewy bodies:comparison with Alzheimer's disease. Dement Geriatr Cogn Disord, 33:273-281(2012).
 
6) Hashimoto M, Yatabe Y, Ishikawa T, et al.:Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients. Dement Geriatr Cogn Dis Extra, 5:244-252(2015).
 
7) 山下英尚, 濱聖司, 藤川徳美, 山脇成人:うつ病は認知症の危険因子か?;脳血管性うつ病と認知機能障害. 精神神経誌, 114(3)283-288(2012).
 
8) 神経変性疾患領域における基盤的調査研究班:平成28年度厚生労働科学研究費補助金難治性疾患等政策研究事業(難治性疾患政策研究事業), 前頭側頭葉変性症の療養の手引き, (祖父江元, 池田 学, 中島健二, 監修)(2017).
 

第2章 : 認知症とかかわりの深い精神疾患, 生活習慣病

P.161 掲載の参考文献
1) Reid LP, Tangen CM, Walston J, et al.;Frailty in older adult:evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 56(3):146-56(2001).
 
2) Kelaiditi E, Cesari M, Canevelli M, et al.:Cognitive frailty:retional and definition from an (I.A.N.A/I.A.G.G.)international consensus group. J Nutr Health Aging, 17(9):716-34(2013).
 
3) Mesholam RI, Moberg PJ, Mahr RN, et al. :Olfaction in neurodegenerative disease ;A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's disease. Arch Neurol, 55(1):84-90(1998).
 
4) 三輪高喜:高齢者の嗅覚障害. Geriatric Medicine, 53:325-9(2015).
 
5) 北村拓朗, 宮崎総一郎, 鈴木秀明:睡眠呼吸障害と認知機能障害, 口咽科, 30(1), :25-29(2017).
 
6) Kral VA, Emery OB:Long-term follpw-up of depressive pseudodementia of aged. Can J Psychiatry, 34(5), :445-6(1989).
 
7) Geerlings MI, den Heijer T, Koudstaal PJ, et al. :History of Depression, Depressive Symptoms and Medical Temporal Lobe Atrophy and Risk of Alzheimer Disease, Neurology 770(15), 1258-64(2008).
 
8) Byers AL, Yaffe K:Depression and risk of developing dementia, Nat Rev Neurol, 7(6):323-31(2011).
 
9) 松沢大樹:目で見る脳とこころ. 日本放送出版協会, 東京(2003).
 
10) Schelline YI, Wang PW, Gado HM, et al.:Hippocampal atrophy in recurrent major depression, Proc. Natl. Acad. Sci., 93(9):3908-13(1996).
 
11) 馬場 元:うつ病から認知症への移行. 老年期認知症研究会誌, 21(11):88-97(2017).
 
12) Namekawa Y, Baba H, Arai H, et al.:Heterogeneity of elderly depression;Increased risk of Alzheimer's disease and Aβprotein metabolism. Prog Neuropsy Biol Psy, 43(3):203-8(2013).
 
13) 岡 靖哲:認知症における睡眠障害. 臨床神経学, 54(12):994-6(2014).
 
14) Adam PS, Alyssa AG, Yang A, et al.:Self-reported sleep and Amyloid depression in community-Dwelling older adults. JAMA Neurology, 70(12):1537-43(2013).
 
15) Ooms S, Overeem S, Besse K, et al.:Effect of 1nightof total sleep deprivation on cerebrospinal fluid β-Amyloid 42 in healthy middle-aged men A Randomized Clinical Trial. JAMA Neurol., 71(8):971-7(2014).
 
16) Brendan PL, Randall JB:Amyloid-β diurnal pattern;possible role of sleep in Alzheimer's disease pathogenesis. Neurology of Aging, 35:529-534(2014).
 
17) Weller RO, Subash M, Person SD, et al.:Perivascular draiage of amyloidbeta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol, 18(2):253-66 (2008).
 
18) Mawuenyega KG, Sigurdson W, Ovod V, et al.:Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science, 330(6012):1774(2010).
PubMed
19) Xie L, Kang H, Nedergaard M, et al:Sleep Drives Metabolite Clearance From the Adult Brain. Science, 342(6156):373-7(2013).
 
20) 井上雄一:認知症と睡眠障害. 認知神経科学, 17(1):26-31(2015).
 
21) Weller RO, Djuanda E, Yow HY, et al. :Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol, 117(1):1-14(2009).
 
22) 新堂 晃:脳小血管病とAlzheimer病アミロイドβクリアランスシステムとしてのグリンパティック系. 神経治療学, 36(4):524-7(2019).
 
23) 羽生春夫:糖尿病性認知症;病態・診断から治療・ケアまで. 医学と看護社, 東京(2019).
 
24) Andreetto E, Yan LM, Tatarek-Nossol M, et al.:Identification of Hot Regions of the Ab-IAPP Interaction Interface as High-Affinity Binding Sites in both Cross- and Self-Association. Angew. Chem. Int., Ed., 49(17):3081-5(2010).
 
25) Yan LM, Velkova A, Kapurniotu A:Molecular Characterization of the Hetero-Assembly of b-Amyloid Peptide with Islet Amyloid Polypeptide. Current Pharmaceutical Design, 20(8):1182-1191(2014).
 
26) Miklossy J, Qing H, Radenvic A, et al.:Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neuroriol Aging, 31(9):1503-15(2010).
 
27) Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, et al.:Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease. Annals of neurology, 86(4):539-51(2019).
 
P.171 掲載の参考文献
1) Barnes DE, Yaffe K:The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet neurology, 10(9):819-828(2011).
 
2) 馬場元:認知症の危険因子と防御因子;うつ病・双極性障害と認知症. BRAIN and NERVE, 68(7):753-765(2016).
 
3) 馬場元:うつ病と認知症との関連;リスクか部分症状か. 老年精神医学雑誌, 29(1):20-28(2018).
 
4) 馬場元:うつ病と認知症の関係;うつ病診療医の立場から. Pharma Medica, 38(8):15-20(2020).
 
5) Byers AL, Yaffe K :Depression and risk of developing dementia. Nature reviews. Neurology, 7(6):323-331(2011).
 
6) Baba H, Nakano Y, Maeshima H, et al. :Metabolism of amyloid-beta protein may be affected in depression. The Journal of clinical psychiatry, 73(1):115120(2012).
 
P.179 掲載の参考文献
1) 三島和夫:脳内グリンパティックシステムと認知機能障害. (日本睡眠学会編)睡眠学, 226-229, 朝倉書店, 東京(2020).
 
2) Xie L, Kang H, Xu Q, et al.:Sleep drives metabolite clearance from the adult brain. Science, 342:373-377(2013).
 
3) Ju YE, McLeland JS, Toedebusch CD, et al.:Sleep quality and preclinical Alzheimer disease. JAMA Neurol, 70(5):587-593(2013).
 
P.188 掲載の参考文献
1) Witlox J, Eurelings LS, de Jonghe JF, et al. :Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia;a meta-analysis. Jama, 304:443-451(2010).
 
2) van Gool WA, van de Beek D, Eikelenboom P:Systemic infection and delirium;when cytokines and acetylcholine collide. Lancet, 375:773-775(2010).
 
3) Kato M, Kishi Y, Okuyama T, et al.:Japanese version of the Delirium Rating Scale, Revised-98 (DRS-R98-J);reliability and validity. Psychosomatics, 51:425-431(2010).
 
4) Inouye SK, Bogardus ST, Jr., Charpentier PA, et al. :A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 340:669-676(1999).
 
5) Hshieh TT, Yue J, Oh E, et al. :Effectiveness of multicomponent nonpharma-cological delirium interventions;a meta-analysis. JAMA internal medicine, 175:512-520(2015).
 
P.197 掲載の参考文献
1) 羽生春夫:糖尿病性認知症;病態・診断から治療・ケアまで. 医学と看護社, 東京(2019).
 
2) Hanyu H, Hirose D, Fukasawa R, et al. :Guidelines for the clinical diagnosis of diabetes mellitus-related dementia. J Am Geriatr Soc 63(8):1721-1723(2015).
 
3) 日本糖尿病学会・日本老年医学会編:高齢者糖尿病治療ガイド. 26-28, 文光堂, 東京(2018).
 
4) Takenoshita N, Fukasawa R, Ogawa Y, et al:Amyloid and tau positron emission tomography in suggested diabetes-related dementia. Curr Alzheimer Res, 15(11):1062-1069(2018).
 
5) Takenoshita N, Shimizu S, Kanetaka H, et al:Classification of clinically diagnosed Alzheimer's disease associated with diabetes based on amyloid and tau PET results. J Alzheimers Dis, 71(1):261-271(2019).
 
P.206 掲載の参考文献
1) Group SR, Wright JT, Jr, Williamson JD, et al.:A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med, 373(22):2103-2116(2015).
 
2) 日本高血圧学会高血圧治療ガイドライン作成委員会編:高血圧治療ガイドライン2019(JSH2019). ライフサイエンス出版, 東京(2019).
 
3) Group SMIftSR;Williamson JD, Pajewski NM, Auchus AP, et al.:Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia:A Randomized Clinical Trial. JAMA, 321(6):553-561(2019).
 
4) Hughes D, Judge C, Murphy R, et al.:Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment:A Systematic Review and Meta-analysis. JAMA, 323(19):1934-1944(2020).
PubMed
5) Rusanen M, Kivipelto M, Levalahti E, et al.;Heart diseases and long-term risk of dementia and Alzheimer's disease;a population-based CAIDE study. J Alzheimers Dis, 42(1):183-91(2014).
 
6) Livingston G, Sommerlad A, Orgeta V, et al.:Dementia prevention, intervention, and care. Lancet. 390(10113):2673-2734(2017).
 
P.211 掲載の参考文献
1) Cataldo JK, Prochaska JJ, Glantz SA:Cigarette smoking is a risk factor for Alzheimer's Disease;an analysis controlling for tobacco industry affiliation. J Alzheimers Dis, 19(2):465-80(2010).
 
2) Durazzo TC, Mattsson N, Weiner MW:Smoking and increased Alzheimer's disease risk:a review of potential mechanisms. Alzheimers Dement, 10(3):122-45(2014).
 
3) Wang Y, Li X, Wei B, et al. :Association between Chronic Obstructive Pulmonary Disease and Dementia;Systematic Review and Meta-Analysis of Cohort Studies. Dement Geriatr Cogn Dis Extra, 9(2):250-259(2019).
 
4) Shah FA, Pike F, Alvarez K, et al. :Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med, 188(5):586-92(2013).
 
5) Ancoli-Israel S, Klauber MR, Butters N, et al.:Dementia in institutionalized elderly:relation to sleep apnea. J Am Geriatr Soc. 39(3):258-63(1991).
 
P.224 掲載の参考文献
1) H Shimada, H Makizako, S Lee, et al.:Impact of Cognitive Frailty on Daily Activities in Older Persons. 20(7):729-735(2016).
 
2) Feng L, Nyunt MS, Gao Q et al.:Physical Frailty, Cognitive Impairment, and the Risk of Neurocognitive Disorder in the Singapore Longitudinal Aging Studies. 72(3):369-375(2017).
 
3) Tsutsumimoto K, Doi T, Makizako H, et al.:Association of social frailty with both cognitive and physical deficits among older people. J Am Med Dir Assoc, 18(7):603-607(2017).
 
4) Makizako H, Shimada H, Tsutsumimoto K, et al.:Social frailty in community-dwelling older adults as a risk factor for disability. J Am Med Dir Assoc, 16(11):1003e7-1003e11(2015).
PubMed
5) JS Kuiper, M Zuidersma, RC Oude Voshaar, et al.:Social relationship and risk of dementia;A systematic review and meta-analysis of longitudinal cohort studies. Aging Res Rev, 22:39-57(2015).
 
6) Giulia G, Miriam LH, Debora R, et al.:Co-occurrence of cognitive impairment and physical frailty, and incidence of dementia;Systematic review and meta-analysis. Neurosci Biobehav Rev, 107:96-103(2019).
 
P.233 掲載の参考文献
1) Lee CG, Boyko EJ, Barrett-Connor E, et al.:Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care, 34(11):2381-2386(2011).
 
2) Zaslavsky O, Walker R, Crane P, et al.:Glucose Levels and Risk of Frailty. J Gerontol A Biol Sci, 71(9):1223-1229(2016).
 
3) Odden M, Peralta C, Haan M, et al.:Rethinking the association of high blood pressure with mortality in elderly adults;the impact of frailty. Arch Intern Med, 172(15):1162-8(2012).
PubMed
4) Ohara M, Kohara K, Okada Y, et al.:Office-based simple frailty score and central blood pressure predict mild cognitive impairment in an apparently healthy Japanese population;J-SHIPP study. Sci Rep, 7:46419(2017).
 
5) Williamson J, Supiano M, Applegate W, et al.:Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Agede>-75 Years:A Randomized Clinical Trial. JAMA, 315(24):2673-82(2016).
 
6) Onder G, Penninx BW, Balkrishnan R, et al.:Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women;an observational study. Lancet, 359(9310):926-30(2002).
PubMed
7) Greenwood S, Koufaki P, Mercer T, et al.:Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD;a pilot randomized controlled trial. Am J Kidney Dis, 65(3):425-34(2015).
PubMed
P.249 掲載の参考文献
1) 朝田隆:介護負担としてのうつ病のメカニズム;その背景としての患者の生活障害と精神症状・行動異常. Depression Frontier, 9(1):25-30(2011).
 
2) 保坂隆:在宅介護者のうつ病とその対策. 保健師ジャーナル, 667(3):250-253(2011).
 
3) Kielholz P:Diagnose und Therapie der Depression fur den Praktiker. Lehmanns, Munchen(1965).
 
4) 町田いづみ, 保坂隆:高齢社会における介護者の現状と問題点;うつ病および自殺リスクに関して. 最新精神医学, 11(3):261-270(2006).
 
5) 坂口京子, 石田敦:老老介護による介護者の睡眠状況と生活の影響. 最新社会福祉学研究, 9:29-41(2014).
 
6) 菅田勝也, 佐藤鈴子, 永田朝子:夜間介護のための睡眠中断が介護者の睡眠に及ぼす影響;一脳波測定例. 日本看護協会誌, 17(1):75-81(1997).
 
7) Li J, Cesari M, DelCampo N, et al.:Impact of diabetes on caregiver stress in patients with Alzheimer's disease;data from the ICTUS study. International psychogeriatrics, 30(8), 1109-1117(2018).
 
8) Ross A, Schamburek R, Wehrlen L, et al.:Cardiometabolic risk factors and health behaviors in family cagivers. PLoS one, 12(5):e0176408(2017).
 
9) Eleuteri S, Norton MC, Livi F, et al,:Sleep quality as predictor of BMI in non-depressed caregivers of people with dementia. Eating and weight disorders, 23(5):553-560(2018).
 
10) 桜井志保美, 濱本律子, 前川厚子:介護による睡眠障害が介護者の心血管系に及ぼす影響. 木村看護教育振興財団看護研究集録, 15:39-52(2008).
 
11) Peter P, Michael M, Heather M, et al.:Dose caring for spouse with dementia promote cognitive decline? A hypothesis and proposed mechanisms. American Geriatrics Society, 59(5):900-908(2011).
 
12) 伊神敬人:うつ病(2)介護の疲れからうつ病になる. 泌尿器ケア, 18(2):203-5(2013).
 
P.260 掲載の参考文献
1) 色本涼:介護ストレスへの対応と支援. 臨床精神医学, 49(12):1981-1987(2020).
 
2) Adelman RD, Tmanova LL, Delgado D, et al.:Caregiver burden;a clinical review. JAMA, 311(10):1052-60(2014).
 
3) 本田美和子, イヴ・ジネスト, ロゼットマレスコッティ:ユマニチュード入門. 医学書院, 東京(2014).
 
4) ロバート・ポール・リバーマン(西園昌久総監修, 池淵恵美監訳):精神障害と回復;リバーマンのリハビリテーション・マニュアル. 星和書店, 東京(2011).
 

第3章 : 認知症予防のノウハウ

P.270 掲載の参考文献
1) 後藤雅博(編著):効果的な家族教室のために. 家族教室のすすめ方, 金剛出版, 東京(1998).
 
2) 朝田 隆(編著):認知症診療の実践テクニック. 129-130, 医学書院, 東京(2011).
 
3) 繁田雅弘:認知症の精神療法;アルツハイマー型認知症の人との対話. 167-171, HOUSE出版, 神奈川(2020).
 
4) 松本一生:認知症の人の自死(自殺)から学ぶこと. 老年精神医学雑誌, 28(6):641-644(2017).
 
P.277 掲載の参考文献
1) Barnes DE, Yaffe K:The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol, 10(9):819-828(2011).
 
2) Scott I, Cooper C, Leverton M, et al.:Effects of nonpharmacological interventions on functioning of people living with dementia at home;A systematic review of randomized controlled trials. Int J Geriatr Psychiatry, 34(10):1386-1402(2019).
 
3) Wilson BA:Cognitive rehabilitation;how it is and how it might be. J Int Neuropsychol Soc, 33(5):487-496(1997).
 
4) Ihara R, Iwata A, Suzuki K, et al.:Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort. Alzheimers Dement(NY), 4:645-651(2018).
 
P.289 掲載の参考文献
1) 山中克夫, 金田裕子, 根本みゆき,ほか:軽度認知障害(MCI)の人やその家族が悩みや支えと感じていること;過去, 現在, 将来の視点から. 第21回日本老年行動科学会口頭発表(2018).
 
2) 筑波大学附属病院認知力アップデイケア:http://www.tsukuba-psychiatry.com/dc/
 
3) 筑波大学附属病院認知力アップデイケア☆プロモーション動画:https://youtu.be/97OlX0PZzO4
 
P.298 掲載の参考文献
1) 認知症施策推進関係閣僚会議:認知症施策推進大綱 (https://www.mhlw.go.jp/content/000522832.pdf)
 
2) 内閣府:認知症に関する世論調査 (https://survey.gov-online.go.jp/tokubetu/r01/r01-ninchisho.pdf)
 
3) Yalom ID, Vinogradov S:Concise Guide to Group Psychotherapy. American Psychiatric Press Washington DC. (1989).
 
P.306 掲載の参考文献
1) ProchaskaJ O, Velicer W F:The transtheoretical model of health behavior change. AmJ Health Promot, 12(1):38-48(1997).
 
2) Bandura A.:Self-efficacy;Toward a unifying theory of behavioral change. Psychological Review, 84(2):191-215(1977).
 
3) Maddux J E(Ed):Self efficacy adaptation, and adjustment:Theory, research, and applications. Springer, New York(1995).
 
4) 矢冨直美, 宇良千秋:「地域型認知症予防プログラム」実践ガイド. 中央法規, 東京(2008).
 
P.330 掲載の参考文献
1) 田口真源:岐阜県西濃地区の認知症について;オレンジ手帳のICT化を利用した4層構造. 日本精神科病院協会雑誌, 333(5):481-488(2014).
 
2) 田口真源:過疎化が進む中山間部の認知症患者と自動車運転;生活支援の視点から. 日本精神科病院協会雑誌, 35(5):47-55(2016).
 
3) 国土交通省国土政策局(2015):「『小さな拠点」づくりガイドブック」(https://www.mlit.go.jp/common/000992103.pdf).
 

書評

最近チェックした商品履歴

Loading...